Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology

Detalhes bibliográficos
Autor(a) principal: Vaz, Margarida Isabel Nascimento
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/28407
Resumo: Alzheimer’s disease (AD) is a devastating worldwide disease and the main cause of dementia. In its pathology, are include two main hallmarks: the extracellular deposition of Aβ peptides, formed in amyloidogenic processing of APP, that aggregate into senile plaques (SP) and the intracellular formation of neurofibrillary tangles (NFT), aggregates of hyperphosphorylated tau protein. Tau hyperphosphorylation occurs due to increased kinase activity (including GSK3β and CDK5) and impaired protein phosphatase activity (PP2A, PP1 and PP2B). Neuroinflammation is a crucial event in AD pathogenesis, during which microglia and astrocytes are constitutively activated, leading to massive production of cytokines. These molecules may alter APP amyloidogenic processing, Aβ aggregation or tau phosphorylation. Among cytokines, chemokines seem to have an important role in AD progression. In the present work, chemokines interleukin 8 (IL-8) and monocyte chemoattractant protein 1 (MCP-1) impact on tau phosphorylation was addressed. Additionally, the effect of these chemokines on kinases (GSK3β and CDK5) and phosphatase (PP1 and PP2A), important in this process, was evaluated. For both chemokines, a significant increase in ptau S396 levels was observed at longer incubation periods and higher chemokines concentration. Further, results regarding GSK3β support that this is not the main involved kinase in this process. However, preliminary results suggest that CDK5, PP1 and PP2A can have a role in tau increased phosphorylation, promoted by chemokines. This work supports the involvement of chemokines on tau hyperphosphorylation and potentially in NFT formation, that consequently result in AD neurodegeneration. At a disease view, this thesis allowed a better understanding of molecular mechanisms that underling the disease pathology, highlighting the role of inflammation in this process.
id RCAP_5841f9d4632b44e5c8b05245f9f16953
oai_identifier_str oai:ria.ua.pt:10773/28407
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathologyAlzheimer’s DiseaseNeuroinflammationChemokinesIL-8MCP-1TauPhosphorylationKinases and PhosphatasesAlzheimer’s disease (AD) is a devastating worldwide disease and the main cause of dementia. In its pathology, are include two main hallmarks: the extracellular deposition of Aβ peptides, formed in amyloidogenic processing of APP, that aggregate into senile plaques (SP) and the intracellular formation of neurofibrillary tangles (NFT), aggregates of hyperphosphorylated tau protein. Tau hyperphosphorylation occurs due to increased kinase activity (including GSK3β and CDK5) and impaired protein phosphatase activity (PP2A, PP1 and PP2B). Neuroinflammation is a crucial event in AD pathogenesis, during which microglia and astrocytes are constitutively activated, leading to massive production of cytokines. These molecules may alter APP amyloidogenic processing, Aβ aggregation or tau phosphorylation. Among cytokines, chemokines seem to have an important role in AD progression. In the present work, chemokines interleukin 8 (IL-8) and monocyte chemoattractant protein 1 (MCP-1) impact on tau phosphorylation was addressed. Additionally, the effect of these chemokines on kinases (GSK3β and CDK5) and phosphatase (PP1 and PP2A), important in this process, was evaluated. For both chemokines, a significant increase in ptau S396 levels was observed at longer incubation periods and higher chemokines concentration. Further, results regarding GSK3β support that this is not the main involved kinase in this process. However, preliminary results suggest that CDK5, PP1 and PP2A can have a role in tau increased phosphorylation, promoted by chemokines. This work supports the involvement of chemokines on tau hyperphosphorylation and potentially in NFT formation, that consequently result in AD neurodegeneration. At a disease view, this thesis allowed a better understanding of molecular mechanisms that underling the disease pathology, highlighting the role of inflammation in this process.A doença de Alzheimer (DA) é uma doença devastadora e a principal causa de demência a nível mundial. Na sua patologia estão incluídas duas principais características: a deposição extracelular de péptidos Aβ, formados durante o processamento amiloidogénico da APP, que agregam em placas senis (SP) e a formação de traças neurofibrilares (NFT), agregados de proteína tau hiperfosforilada. A hiperfosforilação da tau ocorre devido ao aumento da atividade de proteínas cinases (incluindo a GSK3β e a CDK5) e à diminuição da atividade de proteínas fosfatases (PP2A, PP1 e PP2B). A neuroinflamação é um evento crucial na patogénese da DA, durante o qual, a microglia e os astrócitos são constitutivamente ativados, o que leva a uma produção massiva de citocinas. Estas moléculas podem alterar o processamento amiloidogénico da APP, a agregação do Aβ ou a fosforilação da tau. Entre as citocinas, as quimiocinas parecem ter um papel importante na progressão da DA. No presente trabalho foi avaliado o impacto das quimiocinas, interleucina 8 (IL-8) e proteína quimiotática de monócitos 1 (MCP-1), na fosforilação da tau. Para além disso, o efeito destas quimiocinas na atividade de cinases (GSK3β e CDK5) e nas fosfatases (PP1 e PP2A) importantes neste processo também foi avaliado. Para as duas quimiocinas, foi observado um aumento significativo nos níveis de pTau S396 para os períodos de incubação mais longos e nas concentrações de quimiocinas mais elevadas. Além disso, os resultados em relação à GSK3β indicam que esta não é a cinase maioritariamente envolvida neste processo. No entanto, resultados preliminares sugerem que a CDK5, a PP1 e a PP2A podem desempenhar um papel no aumento da fosforilação da tau, promovido pelas quimiocinas. Este trabalho suporta o envolvimento das quimiocinas no estado de hiperfosforilação da tau e potencialmente na formação de NFT que, consequentemente resultam em neurodegeneração na DA. Do ponto de vista da doença, esta tese permite uma melhor compreensão dos mecanismos moleculares que estão na base da patologia, evidenciando o papel da inflamação neste processo.2019-122019-12-01T00:00:00Z2021-12-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/28407engVaz, Margarida Isabel Nascimentoinfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:54:57Zoai:ria.ua.pt:10773/28407Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:00:57.955159Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
title Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
spellingShingle Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
Vaz, Margarida Isabel Nascimento
Alzheimer’s Disease
Neuroinflammation
Chemokines
IL-8
MCP-1
Tau
Phosphorylation
Kinases and Phosphatases
title_short Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
title_full Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
title_fullStr Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
title_full_unstemmed Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
title_sort Chemokines effect on kinases and phosphatases involved in Alzheimer’s disease pathology
author Vaz, Margarida Isabel Nascimento
author_facet Vaz, Margarida Isabel Nascimento
author_role author
dc.contributor.author.fl_str_mv Vaz, Margarida Isabel Nascimento
dc.subject.por.fl_str_mv Alzheimer’s Disease
Neuroinflammation
Chemokines
IL-8
MCP-1
Tau
Phosphorylation
Kinases and Phosphatases
topic Alzheimer’s Disease
Neuroinflammation
Chemokines
IL-8
MCP-1
Tau
Phosphorylation
Kinases and Phosphatases
description Alzheimer’s disease (AD) is a devastating worldwide disease and the main cause of dementia. In its pathology, are include two main hallmarks: the extracellular deposition of Aβ peptides, formed in amyloidogenic processing of APP, that aggregate into senile plaques (SP) and the intracellular formation of neurofibrillary tangles (NFT), aggregates of hyperphosphorylated tau protein. Tau hyperphosphorylation occurs due to increased kinase activity (including GSK3β and CDK5) and impaired protein phosphatase activity (PP2A, PP1 and PP2B). Neuroinflammation is a crucial event in AD pathogenesis, during which microglia and astrocytes are constitutively activated, leading to massive production of cytokines. These molecules may alter APP amyloidogenic processing, Aβ aggregation or tau phosphorylation. Among cytokines, chemokines seem to have an important role in AD progression. In the present work, chemokines interleukin 8 (IL-8) and monocyte chemoattractant protein 1 (MCP-1) impact on tau phosphorylation was addressed. Additionally, the effect of these chemokines on kinases (GSK3β and CDK5) and phosphatase (PP1 and PP2A), important in this process, was evaluated. For both chemokines, a significant increase in ptau S396 levels was observed at longer incubation periods and higher chemokines concentration. Further, results regarding GSK3β support that this is not the main involved kinase in this process. However, preliminary results suggest that CDK5, PP1 and PP2A can have a role in tau increased phosphorylation, promoted by chemokines. This work supports the involvement of chemokines on tau hyperphosphorylation and potentially in NFT formation, that consequently result in AD neurodegeneration. At a disease view, this thesis allowed a better understanding of molecular mechanisms that underling the disease pathology, highlighting the role of inflammation in this process.
publishDate 2019
dc.date.none.fl_str_mv 2019-12
2019-12-01T00:00:00Z
2021-12-20T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/28407
url http://hdl.handle.net/10773/28407
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137665339097088